Unified Communications Industry News

TMCNet:  Stock to Watch: Chelsea Therapeutics International Down 7.4% (CHTP)

[December 28, 2012]

Stock to Watch: Chelsea Therapeutics International Down 7.4% (CHTP)

Dec 28, 2012 (SmarTrend(R) Spotlight via COMTEX) -- Chelsea Therapeutics International (NASDAQ:CHTP) is one of today's worst performing penny stocks, down 7.4% to $0.75 on 1.5x average daily volume. Thus far today, Chelsea Therapeutics International has traded 2.1 million shares, vs. average volume of 1.4 million shares per day. The stock has underperformed the Dow (-7.7% to the Dow's -0.6%) and underperformed the S&P 500 (-7.7% to the S&P's -0.5%) during today's trading.

Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders.

Chelsea Therapeutics International (NASDAQ:CHTP) has potential upside of 368.0% based on a current price of $0.75 and analysts' consensus price target of $3.50. The stock should run into initial resistance at its 50-day moving average (MA) of $1.35 and subsequent resistance at its 200-day MA of $1.56.

Chelsea Therapeutics International share prices have moved between a 52-week high of $5.40 and a 52-week low of $0.70 and are now trading 7% above that low price at $0.75 per share. Over the last five market days, the 200-day moving average (MA) has gone down 2.5% while the 50-day MA has declined 1.8%.

SmarTrend recommended that its subscribers protect gains by selling shares of Chelsea Therapeutics International on December 5th, 2012 by issuing a Downtrend alert when the shares were trading at $1.16. Since that call, shares of Chelsea Therapeutics International have fallen 29.9%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Unified Communications 's Homepage ]